Skip to main content

BNTX · BioNTech SE · Analyst Estimates

Track BNTX — free
$86.00 +0.40 (+0.47%) Play latest call Q3 2026 earnings call transcript
Market Cap
$21.22B
Shares
247.93M
Volume · Nov 16 510.65K Avg daily vol (3M) 1.23M

Analyst Estimates

Compare analyst forecasts for BioNTech SE across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-14 20:20 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
-6.11
-5.09
-4.18
9
-4.68
-4.78
-4.63
-4.97
3
4
2
3
Revenue
EUR
Publication date not stated
1.79B
1.85B
2.09B
16
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
-7.69
-4.73
-3.45
10
-4.81
-4.89
-4.90
-4.86
4
6
1
1
Revenue
EUR
Publication date not stated
1.30B
1.86B
2.25B
17
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
-2.35
-1.77
-1.25
5
-0.84
-0.75
-0.79
-0.79
3
4
— —
Revenue
EUR
Publication date not stated
278.00M
392.49M
600.00M
10
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
-1.89
-1.89
-1.89
1
-1.70
-1.70
-1.70
-1.70
0
0
0
0
Revenue
EUR
Publication date not stated
153.60M
153.60M
153.60M
1
— — — — — — — —
Key facts CIK 1776985 CUSIP 09075V102 13F (30d) 239 filings 212 filers Visit website Investor relations